Development of MDCK-based quadrivalent split seasonal influenza virus vaccine with high safety and immunoprotection: A preclinical study.
Zhang J, Nian X, Liu B, Zhang Z, Zhao W, Han X, Ma Y, Jin D, Ma H, Zhang Q, Qiu R, Li F, Gong Z, Li X, Yang Y, Tian Y, Zhou L, Duan K, Li X, Ma Z, Yang X.
Zhang J, et al. Among authors: gong z.
Antiviral Res. 2023 Aug;216:105639. doi: 10.1016/j.antiviral.2023.105639. Epub 2023 Jun 1.
Antiviral Res. 2023.
PMID: 37270159
Free article.